RU2005132175A - Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию - Google Patents

Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию Download PDF

Info

Publication number
RU2005132175A
RU2005132175A RU2005132175/15A RU2005132175A RU2005132175A RU 2005132175 A RU2005132175 A RU 2005132175A RU 2005132175/15 A RU2005132175/15 A RU 2005132175/15A RU 2005132175 A RU2005132175 A RU 2005132175A RU 2005132175 A RU2005132175 A RU 2005132175A
Authority
RU
Russia
Prior art keywords
formula
derivative
morpholinylanthracycline
combined preparation
radiation therapy
Prior art date
Application number
RU2005132175/15A
Other languages
English (en)
Russian (ru)
Inventor
Мари Кристина Роза ДЖЕРОНИ (IT)
Мария Кристина Роза Джерони
Мари Адель ПАЧЧИАРИНИ (IT)
Мария Адель ПАЧЧИАРИНИ
Антонино СУАРАТО (IT)
Антонино Суарато
Original Assignee
Фармация Италия С.П.А. (It)
Фармация Италия С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Италия С.П.А. (It), Фармация Италия С.П.А. filed Critical Фармация Италия С.П.А. (It)
Publication of RU2005132175A publication Critical patent/RU2005132175A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2005132175/15A 2003-03-18 2004-03-03 Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию RU2005132175A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03075781.9 2003-03-18
EP03075781 2003-03-18

Publications (1)

Publication Number Publication Date
RU2005132175A true RU2005132175A (ru) 2006-01-27

Family

ID=33016931

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005132175/15A RU2005132175A (ru) 2003-03-18 2004-03-03 Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию

Country Status (8)

Country Link
EP (1) EP1603575A2 (fr)
AU (1) AU2004222526A1 (fr)
BR (1) BRPI0408494A (fr)
CA (1) CA2519289A1 (fr)
MX (1) MXPA05009851A (fr)
NO (1) NO20054349L (fr)
RU (1) RU2005132175A (fr)
WO (1) WO2004082579A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2715902C2 (ru) * 2014-11-05 2020-03-04 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Функционализированные производные морфолинилантрациклина

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006292482A1 (en) * 2005-09-16 2007-03-29 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
US8940334B2 (en) 2007-05-11 2015-01-27 Nerviano Medical Sciences S.R.L. Pharmaceutical composition of an anthracycline
US8742076B2 (en) 2008-02-01 2014-06-03 Genentech, Inc. Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
CN102159248B (zh) 2008-07-15 2013-09-11 健泰科生物技术公司 蒽环类衍生物缀合物、它们的制备方法以及它们作为抗肿瘤化合物的用途
KR101897307B1 (ko) 2010-12-02 2018-09-10 네르비아노 메디칼 사이언시스 에스.알.엘. 모르폴리닐 안트라사이클린 유도체의 제조 방법
EP3191134B1 (fr) 2014-09-12 2019-11-20 Genentech, Inc. Intermédiaires disulfure d'anthracycline, conjugué anticorps-médicaments et procédés

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710564A (en) * 1985-01-18 1987-12-01 Microbial Chemistry Research Foundation Anthracycline compounds
GB2172594B (en) * 1985-03-22 1988-06-08 Erba Farmitalia New morpholino derivatives of daunorubicin and doxorubicin
GB2296495B (en) * 1994-12-23 1998-04-15 Erba Carlo Spa Anthracycline derivatives
GB2315067B (en) * 1996-07-11 2000-02-16 Pharmacia Spa Morpholinyl anthracycline derivatives
ES2299692T3 (es) * 2002-04-02 2008-06-01 Nerviano Medical Sciences S.R.L. Terapia combinada contra tumores que comprende derivados de distmicina acriloil sustituido y radioterapia.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2715902C2 (ru) * 2014-11-05 2020-03-04 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Функционализированные производные морфолинилантрациклина

Also Published As

Publication number Publication date
WO2004082579A3 (fr) 2004-11-11
NO20054349L (no) 2005-10-11
WO2004082579A2 (fr) 2004-09-30
CA2519289A1 (fr) 2004-09-30
BRPI0408494A (pt) 2006-04-04
EP1603575A2 (fr) 2005-12-14
MXPA05009851A (es) 2005-12-06
AU2004222526A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
RU2757373C2 (ru) Комбинированная терапия противоопухолевым алкалоидом
RU2010133489A (ru) Применение ингибиторов гамма-секретазы для лечения рака
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
RU2012106620A (ru) Комбинации и способы введения терапевтических средств и комбинированной терапии
WO2004043389B1 (fr) Procedes de traitement du cancer et procedes connexes
EP2387401A1 (fr) Méthode de traitement d'un cancer colorectal
EP1014990B1 (fr) Combinaison antitumorale de 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum
RU2014144254A (ru) Комбинированные продукты, содержащие ингибиторы тирозинкиназ, и их применение
MX2013013014A (es) Metodo para el tratamiento de tumores solidos avanzados.
BR112021007283A2 (pt) método de tratamento de um câncer ou câncer refratário
KR20100031759A (ko) 흑색종의 치료
CA2483826A1 (fr) Traitement de l'hepatome et d'autres maladies cancereuses
RU2005132175A (ru) Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию
US6689811B2 (en) Method of using caffeic acid phenethyl ester and analogs thereof as radiation sensitizers
CA2435921A1 (fr) Methode de therapie anticancereuse
JP2006523664A5 (fr)
TW201306833A (zh) 包含康布列塔司他汀（ｃｏｍｂｒｅｔａｓｔａｔｉｎｓ）族衍生物及西妥昔單抗（ｃｅｔｕｘｉｍａｂ）之組合
EP3010508B1 (fr) Combinaison de ro5503781, de capécitabine et d'oxaliplatine pour le traitement du cancer
RU2314807C2 (ru) Комбинированная противоопухолевая терапия, включающая использование замещенных акрилоилпроизводных дистамицина и лучевой терапии
EP3127544B1 (fr) Médicament antitumoral contenant un complexe de platine antitumoral et promoteur de l'effet antitumoral
WO2024104561A1 (fr) Combinaisons thérapeutiques de capivasertib et de vénétoclax
US20030139430A1 (en) Use of organic compounds
TW202333675A (zh) 用於治療癌症之組合療法之用途
RU2021126668A (ru) Комбинированная терапия для применения в лечении рака
WO2004073719A1 (fr) Traitement combine comprenant un derive d'indolopyrrolocarbazole et un autre agent antitumoral

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20070410